Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India

Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain

(2013) Arindam Sarkar et al.   BMC INFECTIOUS DISEASES

Production and Characterization of Monoclonal Antibodies to Japanese Encephalitis Virus

(2013) Hiroshi SHIMODA et al.   JOURNAL OF VETERINARY MEDICAL SCIENCE

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

(2012) Elina O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial

(2012) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine

(2012) Yi-Chin Fan et al.   PLoS Neglected Tropical Diseases

New Japanese encephalitis vaccines: alternatives to production in mouse brain

(2011) Scott B Halstead et al.   Expert Review of Vaccines

Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia

(2011) X.-L. Pan et al.   JOURNAL OF VIROLOGY

Isolation and Genetic Characteristics of Human Genotype 1 Japanese Encephalitis Virus, China, 2009

(2011) Jiu-Song Zhang et al.   PLoS One

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers

(2011) Yvonne Van Gessel et al.   VACCINE

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds

(2010) Kulkanya Chokephaibulkit et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity

(2010) Ronald B. Reisler et al.   VACCINE

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

(2010) Joseph Torresi et al.   VACCINE

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE